These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11015996)

  • 1. [Long-term outcome of preoperative chemotherapy with 5'-deoxy-5-fluorouridine (5'-DFUR) for gastric cancer].
    Kobayashi T; Kimura T
    Gan To Kagaku Ryoho; 2000 Sep; 27(10):1521-6. PubMed ID: 11015996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of 5'-deoxy-5-fluorouridine (5'-DFUR) administration before surgery for advanced gastric and colonic cancers--activity of pyrimidine nucleoside phosphorylase (PyNPase) and serum immunosuppressive acidic protein (IAP)].
    Murakami N; Hirano M; Saito H; Nagao S; Arano Y; Kikuchi T; Ishikawa N; Kurokawa M; Kitsukawa H
    Gan To Kagaku Ryoho; 1996 Dec; 23(14):1959-66. PubMed ID: 8978804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach].
    Kimura T; Kobayashi T; Nakaya Y; Iida T; Uchimura M; Murohisa B; Nagashima T; Matsumoto Y; Kitamura H; Shibata M
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1051-6. PubMed ID: 7611757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area].
    Satoh B; Ohtoshi M; Ishida Y; Hen-mi K; Kaneko I; Soda M; Sugihara J; Shibagaki F; Iwai N; Nakamura T; Yamasaki T; Matsumoto S
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):359-64. PubMed ID: 9492829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/platelet-derived endothelial cell growth factor and histological prognostic factor, and influences of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase levels. 5'-DFUR Joint Research Group in the Osaka Area for Gastric Cancer].
    Yamasaki Y; Kuwata K; Hioki K; Sowa M; Hirakawa K; Okajima K; Isozaki H; Iwanaga T; Furukawa H; Nakano H; Watanabe A; Takami M; Tsukahara Y; Matsunaga S; Kikkawa N; Gotoh T; Tokuda H; Takahashi S; Toyohara M; Yagi M; Takebayashi J; Nakajima T; Miyazaki H; Kuwata H; Nakazato H
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1549-56. PubMed ID: 9725048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of preoperative oral 5'-DFUR on PyNPase level in gastrointestinal malignant tumor tissues].
    Wang WJ; Shi D; Wang SM
    Ai Zheng; 2003 Jun; 22(6):653-7. PubMed ID: 12948420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antitumor effect of 5'-DFUR and PyNPase activity in colorectal cancer].
    Honda M; Tanaka Y; Matsuo Y; Yamamoto S; Hazama K; Inoue Y; Takao T; Fushimi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):939-43. PubMed ID: 10396321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.
    Zhao WH; Wang SF; Ding W; Sheng JM; Ma ZM; Teng LS; Wang M; Wu FS; Luo B
    World J Gastroenterol; 2006 Mar; 12(9):1356-61. PubMed ID: 16552801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of 5'-deoxy-5-fluorouridine in human digestive organ cancer xenografts and pyrimidine nucleoside phosphorylase activity in normal and neoplastic tissues from human digestive organs.
    Nio Y; Kimura H; Tsubono M; Tseng CC; Kawabata K; Masai Y; Hayashi H; Meyer C; Fukumoto M; Tobe T
    Anticancer Res; 1992; 12(4):1141-6. PubMed ID: 1386969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of gastric cancer in which long-term administration of 5'-deoxy-5-fluorouridine (5'-DFUR) proved effective].
    Koda T; Kurahori T; Iwao N; Sumi S; Sonoda T; Yanagimoto H; Miyaji J; Okahisa N
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2571-4. PubMed ID: 3039923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of intratumor administration of OK-432 on the tumor selectivity of 5'-DFUR].
    Ogawa K; Katsube T; Konno S; Miura K; Wakasugi S; Watanabe T; Shimakawa T; Ishikawa S; Naritaka Y; Yagawa H
    Gan To Kagaku Ryoho; 1995 Dec; 22(14):2095-100. PubMed ID: 8607621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of response to 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with inoperable advanced gastric cancer by immunostaining of thymidine phosphorylase/platelet-derived endothelial cell growth factor.
    Koizumi W; Saigenji K; Nakamaru N; Okayasu I; Kurihara M
    Oncology; 1999 Apr; 56(3):215-22. PubMed ID: 10202277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical effect of 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Nakano Y; Ohota J; Fujita M; Taguchi T
    Gan No Rinsho; 1985 May; 31(6 Suppl):746-50. PubMed ID: 3162050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized comparison of continuous and intermittent oral administration of 5'-deoxy-5-fluorouridine in the treatment of advanced gastric cancer; a phase II trial by the Multi-institutional Cooperative Study Group].
    Niitani H; Kurihara M; Hasegawa K; Hatta Y; Suwa T; Tsuboi E; Yasui A; Yoshimori K; Kawachi M; Taguchi S
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3345-50. PubMed ID: 2961307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination phase II study of weekly paclitaxel and 5'-DFUR for unresectable or recurrent gastric cancer.
    Yoshino S; Furuya T; Shimizu R; Ozasa H; Nishimura T; Fukuda S; Kawaoka T; Hazama S; Oka M
    Anticancer Res; 2013 Jun; 33(6):2629-33. PubMed ID: 23749919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
    Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5'-DFUR and OK-432 on cytokines and thymidine phosphorylase in tumor tissue of gastric cancer patients.
    Ohwada S; Ogawa T; Izumi M; Inoue T; Teshigawara O; Ikeya T; Kusaba T; Roppongi T; Iino Y; Morishita Y
    Anticancer Res; 1997; 17(3C):2313-8. PubMed ID: 9216708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of doxifluridine and correlation to in vitro sensitivity of anticancer drugs in patients with colorectal cancer.
    Yamaue H; Tanimura H; Kono N; Aoki Y; Tabuse K; Uchiyama K; Takifuji K; Iwahashi M; Tani M
    Anticancer Res; 2003; 23(3B):2559-64. PubMed ID: 12894541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy after curative resection for gastric cancer-5'-DFUR + cisplatin vs 5'-DFUR].
    Fujitani K; Kobayashi K; Tamaki Y; Tsujinaka T; Hirao M
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):61-5. PubMed ID: 11816479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine.
    Nishina T; Hyodo I; Miyaike J; Inaba T; Suzuki S; Shiratori Y
    Eur J Cancer; 2004 Jul; 40(10):1566-71. PubMed ID: 15196541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.